
|
|
|
| For 100 years, C. R. Bard, Inc. has committed its resources to creating innovative products and services that meet the needs of healthcare providers and patients. Today, Bard is a worldwide leader in products that focus on Disease State Management in three key areas: Vascular, Urology and Oncology. To complement these areas, Bard has a complete line of advanced Surgical Specialty Products and Services. |
|
|
Bard® is proud to be a premier sponsor of the 2008 Cleveland Clinic Innovation Summit. Join Bard’s CEO, Tim Ring, and 800 health care leaders November 10-12, 2008.
To learn more visit: www.clevelandclinic.org /innovations
|
|
Please note that the information in each of the above press releases is only current as of the date of the release. C. R. Bard, Inc. undertakes no obligation to update the information in the press releases to reflect new information, the occurrence of future events or circumstances, or otherwise. |
|
|
VenafloTMII
Vascular Graft
The VenafloTM II Vascular Graft is designed to improve patency for arteriovenous access by optimizing hemodynamic flow patterns at the venous anastomosis.
|